What Analysts Are Saying About Voyager Therapeutics Stock
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Voyager Therapeutics (NASDAQ:VYGR) over the past three months, with a range of price targets from $8.00 to $30.00. The average price target has declined by 2.27%. The company has faced a significant revenue decline but maintains strong financial metrics in other areas.
July 31, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Voyager Therapeutics has received mixed analyst ratings with price targets ranging from $8.00 to $30.00. The average price target has decreased by 2.27%. Despite a significant revenue decline, the company maintains strong financial metrics in net margin, ROE, ROA, and debt management.
The mixed analyst ratings and slight decrease in average price target suggest a neutral short-term impact on the stock price. The company's strong financial metrics in areas like net margin, ROE, and ROA, despite a significant revenue decline, provide a balanced outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100